85 results about "Arthropathy" patented technology

A spine distraction implant alleviates pain associated with spinal stenosis and facet arthropathy by expanding the volume in the spine canal and / or neural foramen. The implant provides a spinal extension stop while allowing freedom of spinal flexion. An interspinous process implant with a selectably expandable spacer can be placed between adjacent spinous processes. a device implanted between the spinous processes of adjacent vertebrae of the spine can be used for relieving pain associated with the vertebrae and surrounding tissues and structures by maintaining and / or adding distraction between adjacent vertebrae. A tissue expander can be adapted to move from a first insertion position, for ease of implantation between spinous processes, to a second retention position that prevents displacement of the implant. An embodiment of a system can include an implant having a spacer with a thickness and a wing, wherein a first configuration of the wing has a first height substantially similar to the thickness and wherein the wing is adapted to be selectably arranged in a second configuration such that the wing has a second height greater than the first height. A periphery of the implant has a shape generally conformal with a shape of an inner surface of a cannula and a cross-sectional diameter smaller than an inner diameter of the cannula. The cannula is inserted such that a proximal end of the cannula is arranged between the adjacent spinous processes. The implant is then urged into position between the adjacent spinous processes by way of the cannula, and subsequently arranged in a second configuration to fix the implant in position.

The invention relates to a moxibustion medicinal strip, particularly to a moxibustion medicinal strip for treating rheumatic arthralgia, and solves the problem of a relatively slow curative effect of moxibustion purely using moxa sticks. The moxibustion medicinal strip consists of: 1-10g of fennel, 1-20g of dried ginger, 1-20g of frankincense, 1-40g of Curcuma Zedoary, 1-40g of safflower, 1-10g of musk, 1-50g of monkshood, 1-50g of Rhizoma Corydalis, 1-50g of radix clematidis, 1-50g of caulis spatholobi, and the balance moxa, which accounts for 75%-85% of the total weight of the moxibustion medicinal strip. The moxibustion medicinal strip provided by the invention is used for rheumatic and rheumatoid arthritis, and cervical, thoracic and lumbar arthropathy caused by wind, cold, and pathogenic dampness.

The present invention relates to compositions and methods for treating rheumatic diseases, such as psoriasis arthropathica, by administering to a subject a CTLA4 molecule that block endogenous B7 molecules from binding their ligands.

In a multi-modality method for representing functional and morphological exposures of an extremity of patients exhibiting arthritis / arthrosis, and corresponding computer software, images obtained with different imaging modalities are supplied to a computer and displayed at the computer with a default line model of the extremity superimposed on each of the images. A user interacts with the computer to modify the line model as necessary, so that each of the images has a modified line model associated therewith. The images obtained from the different imaging modalities are then superimposed and registered with each other by conforming the respective modified line models with each other. One of the images can be composed of a number of sub-images, obtained at respective joints in the extremity. These individual images of the joint can be fused with the image of the complete extremity, so that in a display of such a fused image, the individual joint images can be selected and displayed.

The invention relates to a method for rapidly detecting a human leucocyte antigen B27 (HLA-B27) and an in-vitro diagnosis kit, which belong to the technical field of medical biology. In the kit, a pair of HLA-B27 specific primers and a specific fluorescent probe are adopted for rapidly detecting the HLA-B27. In the kit, the pair of HLA-B27 specific primer and the specific fluorescent probe can beused for rapidly and accurately detecting HLA-B27 genes in samples such as human peripheral blood and the like, and the kit has the advantages of high specificity, high sensitivity, time saving, labor saving, low cost, high flux and the like, and can be applied to auxiliary diagnosis of multiple spondyloarthropathies which severely endanger human health such as clinical ankylosing spondylitis, Reiter syndrome, psoriatic arthritis, ulcerative colitis accompanying arthropathy, acute anterior tract uveal, and the like.

The present invention provides one kind of plaster for treating rheumatism, wound pain and swelling boil and its preparation process. The plaster is prepared with greenbrier rhizome, cassia, white atractylodes rhizome, peach kernel, viola herb and other Chinese medicinal materials. It is developed based on family handed secret recipe and through combination with modern medicine preparing technology. It is used to treat traumatic injury, muscle and bone contuse, sprain, etc mainly, and may be also used in treating innominate toxic swelling, rheumarthritis, etc., owing to its functions of reducing swelling, stopping pain, lowering blood sedimentation rate, etc.

Novel methods and drug products for treating inflammatory joint diseases such as rheumatoid arthritis and associated arthritides are disclosed. The methods and products employ various serum markers of bone and cartilage metabolism or destruction, including cartilage oligomer matrix protein (COMP) and Receptor activator of NFB ligand (RANKL), as biomarkers to assess the effect of IL-17A antagonists on joint destruction in inflammatory joint diseases.

The present invention provides devices, methods, and kits for reducing joint pain and treating conditions of weight-bearing joints. The methods are accomplished through the use of a cushioned wedged insole or slab that selectively reduces pressure by cushioning impact and redistributing forces away from affected joints or joint compartments. Further, insoles are provided, which mimic the combination of fatty globules and the surrounding restricting fibrous network cushioning structures found in the foot.

An ointment for curing bone arthropathy is a medicine for curing bone arthropathy, which overcomes the defects of other methods. The ointment contains the traditional Chinese raw medicines with the following weight proportion: pangolin, angelica, hemlock parsley, dried body of ground beetle, earthworm, american lopseed, siebold wildginger herb, szechuan aconite, wild aconite, eucommia, leatherleaf millettia, achyranthes root, turmeric, motherwort, Chinese lovage, obscured homalomena rhizome, nodular branch of pine, cibotium barometz, muskiness, rhizoma corydalis and camphor. The preparation method includes the following steps: fully frying pangolin, angelica, hemlock parsley, dried body of ground beetle, earthworm, american lopseed, siebold wildginger herb, szechuan aconite, wild aconite, eucommia, leatherleaf millettia, achyranthes root, turmeric, motherwort, Chinese lovage, obscured homalomena rhizome, nodular branch of pine and cibotium barometz with sesame oil and removing slag; refining oil until water drops become bead and then adding yellow lead; evenly stirring and obtaining the ointment; immersing the ointment in water for 15 to 20 days to clearing fire toxin, adding muskiness, rhizoma corydalis and camphor when ointment is spread. The curing result is as follows: the total number of the cases is 1,763, wherein, 1,473 cases are healed, 290 cases get better and 36 cases are unhealed, thus the total effective rate is 97.8 percent.

The invention relates to a traditional Chinese medicine for treating a degenerative joint disease. The invention comprises traditional Chinese medicine raw material medicines such as prepared rehmannia, woodwardia, codonopsis root, angelica, chiang-huo, tu-huo, ledebouriella root, Sichuan aconite main root (prepared), wild aconite (prepared), dipsacus and cyathula root. The traditional Chinese medicine provided by the invention has the efficacies of tonifying liver and kidney, regulating qi and blood, unblocking the meridians, dispelling the cold-dampness in order to treat the degenerative joint disease; and has been used in clinical applications for many years, and the effect is significant.

Disclosed is a pharmaceutical composition for preventing or treating TRPV1 activity-related or inflammation-related, diseases or conditions, containing a Maillard peptide separated from well-aged traditional soy sauce as an active ingredient. The Maillard peptide in the present invention functions both as a TRPV1 agonist and a TRPV1 antagonist, and further functions as a TRPV1 activity modulator. Therefore, the Maillard peptide can be used for preventing or treating TRPV1 activity-related diseases such as pain, neurological diseases, urgent defecation, inflammatory bowel disease, respiratory diseases, urinary incontinence, overactive bladder, neurogenic / allergic / inflammatory skin diseases, skin, eye or mucosal irritation, hyperacusis, tinnitus, vestibular hypersensitivity, heart disease, etc. The Maillard peptide can further inhibit COX-2 activity, and therefore can be effectively used for preventing or treating inflammation-related diseases or conditions such as rheumatic fever, influenza, cold, throat pain, headaches, toothaches, sprains, neuralgia, synovitis, rheumatoid arthritis, degenerative arthropathies, gout, ankylosing spondylitis, psoriasis, dermatitis, etc.

The invention relates to a drug combination for detumescence and acesodyne and in particular to a drug combination for detumescence and acesodyne, which is made from the raw material of Chinese herbal medicines of plants, and the preparation method and the application of the drug combination. The drug combination for detumescence and acesodyne of the invention consists of ten Chinese herbal medicines of a peony bark, a pricklyash root, a safflower, a root of pseudo-ginseng, a Szechwan aconite, a terebinth, a borneol, a camphor, cinnamon oil and menthol. The invention has the efficacies of activating blood circulation, dispersing blood stasis, extending tract, activating collateral flow, detumescence and acesodyne; the external application can directly remedying partial ill parts; the drugefficacy penetrates quickly, and the stasis, the turgescence and the ache are eliminated fast; the drug combination is a good external anodyne salve for remedying the trauma of muscle, tendon, and parenchyma and the turgescence and the ache which are caused by the bone arthropathy and belong to blood stasis, retardarce and inside invading by cold-dampness.

Disclosed is a product and method for transplanting biological fluids into a host animal (including humans) that have been collected from donor animals. These biological fluids have been purified and processed so that they are a cellular, sterile, pathogen free, and a form that can be stored for considerable periods of time without degradation. In one embodiment, synovial fluid is harvested from a large number of donors to produce the transplantation compound. Donor fluid is collected from a number of joints per animal, and initially screened for obvious abnormalities (clarity, color, viscosity. . . etc.) and accepted or rejected on a joint-by-joint basis at the time of collection. The collected fluid is frozen in the field. Once in a laboratory setting, the fluid is warmed and spun down in a centrifuge. The supernate is collected, filtered, and mixed in large batches while the permeate is discarded. The supernate is re-frozen, lyophilized (freeze-dried) to form a cake and packaged as an individual dose under vacuum. The product is sterile, stable, has a long shelf life and can be readily reconstituted and injected into a joint.